Drug lookup | Fillwise

ABACAVIR & LAMIVUDINE & ZIDOVUDINE

All products: general benefit

Other products in the same Health Canada class (J05AR) — coverage varies; not interchangeable

Abacavir + lamivudine (Kivexa): general benefit
Bictegravir + emtricitabine + tenofovir alafenamide hemifumarate (Biktarvy): general benefit
Cabotegravir + rilpivirine (Cabenuva): general benefit
Cobicistat + elvitegravir + emtricitabine + tenofovir disoproxil (Stribild): general benefit
Cobicistat + darunavir (Prezcobix): general benefit
Cobicistat + darunavir + emtricitabine + tenofovir alafenamide (Symtuza): general benefit

48 more in the class list below

Apo-Abacavir-Lamivudine-Zidovudine · DIN 02416255 · 300mg & 150mg & 300mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.Discontinued 2025-04-17 · checked 2026-09-19

StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.

Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Apo-Abacavir-Lamivudine-Zidovudine · DIN 02416255 Manufacturer: Apotex Inc.; listing date 2016-01-28 Health Canada: Cancelled post market since 2025-04-17 · brand APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE · ATC J05AR04 ZIDOVUDINE, LAMIVUDINE AND ABACAVIR · form Tablet · route Oral · ingredients ABACAVIR (ABACAVIR SULFATE) 300 MG, LAMIVUDINE 150 MG, ZIDOVUDINE 300 MG · company Apotex inc · schedule Prescription

Check this DIN again · Health Canada product record

Apo-Abacavir-Lamivudine-Zidovudine: Formulary list price $13.6425/unit (unit not stated in source; not the patient's cost)

Ministry pays: $13.6425 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90068 · Verify on the e-Formulary ↗ (DIN 02416255)

Source record

DIN 02416255: Apo-Abacavir-Lamivudine-Zidovudine Raw flags: sec3=Y Item: 081800065; group id 59; item number 0118; lccId None; manufacturer id APX Source form: Tab; strength: 300mg & 150mg & 300mg Recorded listing: General benefit Source prices (unrounded): $13.6425; ministry $13.6425 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02416255 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90068

Interchangeable products

Trizivir · DIN 02244757 · $13.6425

Shortage status: not checked (no credentials)

Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.

Other drugs in the same formulary class (08:18 Antivirals) and how they are covered

Matched class: 08:18 Antivirals

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ABACAVIR SULFATE, ABACAVIR SULFATE & LAMIVUDINE, BICTEGRAVIR SODIUM/EMTRICITABINE/TENOFOVIR ALAFENAMIDE HEMIFUMARATE, CABOTEGRAVIR, CABOTEGRAVIR & RILPIVIRINE, COBICISTAT & ELVITEGRAVIR & EMTRICITABINE & TENOFOVIR DISOPROXIL FUMARATE, DARUNAVIR & COBICISTAT, DARUNAVIR & COBICISTAT & EMTRICITABINE & TENOFOVIR ALAFENAMIDE, DELAVIRDINE MESYLATE, DOLUTEGRAVIR, DOLUTEGRAVIR & ABACAVIR & LAMIVUDINE, DOLUTEGRAVIR & RILPIVIRINE, DOLUTEGRAVIR SODIUM/LAMIVUDINE, DORAVIRINE, DORAVIRINE/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ/TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE, ELVITEGRAVIR & COBICISTAT & EMTRICITABINE & TENOFOVIR ALAFENAMIDE, EMTRICITABINE & RILPIVIRINE HCL & TENOFOVIR ALAFENAMIDE HEMIFUMARATE, EMTRICITABINE & RILPIVIRINE HCL & TENOFOVIR DISOPROXIL, EMTRICITABINE & TENOFOVIR DISOPROXIL FUMARATE, ETRAVIRINE, FOSAMPRENAVIR CALCIUM, GANCICLOVIR SODIUM, LAMIVUDINE & ZIDOVUDINE, LOPINAVIR & RITONAVIR, MARAVIROC, NELFINAVIR MESYLATE, RALTEGRAVIR POTASSIUM, RILPIVIRINE HYDROCHLORIDE, RITONAVIR Some products covered without a code (check the product listing): ACYCLOVIR, ATAZANAVIR SULFATE, DARUNAVIR, EFAVIRENZ, LAMIVUDINE, NEVIRAPINE, VALACYCLOVIR 08:18 Antivirals

Full class listing Related classes: 08:08 Anthelmintics, 08:12 Antibiotics, 08:14 Antifungals, 08:16 Antitubercular Agents, 08:20 Plasmodicides (Antimalarials), 08:24 Sulfonamides, 08:30 Antiprotozoals, 08:32 Trichomonacides, 08:36 Urinary Anti-Infectives, 08:40 Miscellaneous Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.

What the Health Canada label says it is for

Product monograph unavailable: no marketed product found